| Patents for A61K 38 - Medicinal preparations containing peptides (316,240) |
|---|
| 02/21/2006 | US7001430 Matrix composition for human grafts/implants |
| 02/21/2006 | CA2423825C New perindopril salt and pharmaceutical compounds containing it |
| 02/21/2006 | CA2356306C Sulfated phosphatidylinositols, their preparation and use |
| 02/21/2006 | CA2259997C Remedies and preventives for stomatitis |
| 02/21/2006 | CA2220301C Osmotic device with delayed activation of drug delivery and complete drug release |
| 02/21/2006 | CA2186224C Amidino derivatives useful as nitric oxide synthase inhibitors |
| 02/21/2006 | CA2091181C Cloning of chicken anaemia dna |
| 02/21/2006 | CA2032381C Viral agent |
| 02/20/2006 | CA2478458A1 Treatment of pediatric multiple sclerosis |
| 02/17/2006 | CA2478138A1 Cxcl10-based diagnosis and treatment of respiratory illnesses |
| 02/16/2006 | WO2006017854A2 Compositions and methods for determining and predicting treatment responses for depression and anxiety |
| 02/16/2006 | WO2006017842A1 Compounds for proteasome enzyme inhibition |
| 02/16/2006 | WO2006017824A2 Igf-bp3-related methods for inhibiting tumor growth |
| 02/16/2006 | WO2006017698A2 Novel statin pharmaceutical compositions and related methods of treatment |
| 02/16/2006 | WO2006017688A2 Combination therapy using transferrin fusion proteins comprising glp-1 |
| 02/16/2006 | WO2006017673A2 Taj in neuronal function |
| 02/16/2006 | WO2006017545A2 Systems and methods for inhibiting metastasis |
| 02/16/2006 | WO2006017541A2 Antidiabetic oral insulin-biguanide combination |
| 02/16/2006 | WO2006017456A2 Chymopapain isoenzymes, compositions, and uses thereof |
| 02/16/2006 | WO2006017251A2 Compositions for delivering peptide yy and pyy agonists |
| 02/16/2006 | WO2006017215A2 Histone deacetylase inhibitors |
| 02/16/2006 | WO2006016930A2 Methods for treating hcv infection |
| 02/16/2006 | WO2006016695A1 Preventive and/or remedy for hyperkalemia containing ep4 agonist |
| 02/16/2006 | WO2006016282A2 Media indexer |
| 02/16/2006 | WO2006016247A2 Lysis/resealing process and device for incorporating an active ingredient in erythrocytes |
| 02/16/2006 | WO2006016078A1 Long-acting colloidal insulin formulation and preparation thereof |
| 02/16/2006 | WO2006015882A2 Treatment of hyperproliferative disease with superantigens in combination with another anticancer agent |
| 02/16/2006 | WO2006001810A3 Improved inhibitor nucleic acids |
| 02/16/2006 | WO2005118630A3 Peptides for the treatment of diabetes |
| 02/16/2006 | WO2005116197A3 Adamts-8 proteins and uses thereof |
| 02/16/2006 | WO2005116068A8 Peptides or peptidic conjugate derivatives of msh and the use thereof for cosmetically fighting against canities |
| 02/16/2006 | WO2005115433A3 Methods for cyclizing synthetic polymers |
| 02/16/2006 | WO2005105064A3 Modulators of frat-lrp interaction in the treatment of bone-related diseases |
| 02/16/2006 | WO2005102379A3 Nucleic acid based assays for identification of fc receptor polymorphisms |
| 02/16/2006 | WO2005094420A3 Materials and methods for treatment of inflammatory and cell proliferation disorders |
| 02/16/2006 | WO2005072380A3 Membrane attack complexes associated with circulating immune complexes |
| 02/16/2006 | WO2005021557A3 Poly-pegylated protease inhibitors |
| 02/16/2006 | WO2005020916A3 Myoblast treatment of diseased or weakened organs |
| 02/16/2006 | WO2004106359A3 Self-assembled peptide-amphiphiles & self-assembled peptide nanofiber networks presenting multiple signals |
| 02/16/2006 | WO2004101600A3 Novel poly(ethylene glycol) modified compounds and uses thereof |
| 02/16/2006 | WO2004082599A3 Combination of an aldosterone receptor antagonist and an anti-diabetic agent |
| 02/16/2006 | WO2004078946A3 Rnai arrays and methods for using the same |
| 02/16/2006 | WO2004047720A3 Methods of inhibiting angiogensis via modification of a lysyl oxidase |
| 02/16/2006 | WO2004043391A3 Modulation of mitogen-activated protein kinase kinase kinase 11 expression |
| 02/16/2006 | WO2004024095A3 ß-L-2'-DEOXYNUCLEOSIDES FOR THE TREATMENT OF RESISTANT HBV STRAINS AND COMBINATION THERAPIES |
| 02/16/2006 | WO2004018697A3 Protease resistant ti-growth hormone releasing hormone |
| 02/16/2006 | WO2003103573A3 Methods for treating a neurological disorder by peripheral administration of a trophic factor |
| 02/16/2006 | WO2003083058A3 Replikin peptides in rapid replication of glioma cells and in influenza epidemics |
| 02/16/2006 | WO2003059248A3 Pigment epithelium derived factor from human plasma and methods of use thereof |
| 02/16/2006 | WO2003050293A3 hGC-1, A GENE ENCODING A MEMBER OF THE OLFACTOMEDIN-RELATED PROTEIN FAMILY |
| 02/16/2006 | WO2003046151A3 Nucleic acid-associated proteins |
| 02/16/2006 | WO2003033720A8 Protein based tnf-alpha variants for the treatment of tnf-alpha related disorders |
| 02/16/2006 | WO2003025129A3 Neurotransmission-associated proteins |
| 02/16/2006 | WO2002081639A3 Gene brcc2 and diagnostic and therapeutic uses thereof |
| 02/16/2006 | US20060037091 Method for producing hypertrophic scarring animal model for identification of agents for prevention and treatment of human hypertrophic scarring |
| 02/16/2006 | US20060037087 Recombinant vectors for treating E coli infections more specifically those that result in post weaning diarrhea or scours |
| 02/16/2006 | US20060036089 33 human secreted proteins |
| 02/16/2006 | US20060036083 Ribosylated human neutrophil peptide-1or an ADP-ribosylated human neutrophil peptide-1; modified antimicrobial activity compared to alpha defensin lacking ADP-ribosylated or ribosylated residue; altered chemotaxis of T cells, altered neutrophil recruitment |
| 02/16/2006 | US20060036073 Neurotrophic and neuroprotective peptides |
| 02/16/2006 | US20060036071 Processes for preparing eptifibatide |
| 02/16/2006 | US20060036070 Immunoglobulin a inducing protein and uses therefor |
| 02/16/2006 | US20060035955 Methods and compositions using selective cytokine inhibitory drugs for treatment and management of cancers and other diseases |
| 02/16/2006 | US20060035867 For inhibition of bone metastases in prostate cancer patients |
| 02/16/2006 | US20060035859 Treating severe and acute viral infections |
| 02/16/2006 | US20060035857 Methods and compositions for the diagnosis and treatment of cancer |
| 02/16/2006 | US20060035856 Purified polypeptides having IL-13 receptor activity |
| 02/16/2006 | US20060035855 Purified polypeptides having IL-13 receptor activity |
| 02/16/2006 | US20060035851 Use of hmgb1 in the treatment of tissue damage and or to promote tissue repair |
| 02/16/2006 | US20060035849 Methods and composition for modulating type I muscle formation using pgc-1 alpha |
| 02/16/2006 | US20060035839 Novel multimeric molecules, the preparation method thereof and use of same for the preparation of medicaments |
| 02/16/2006 | US20060035838 Drug therapy for celiac sprue |
| 02/16/2006 | US20060035837 Compounds that inhibit Hsp90 protein-protein interactions with IAP proteins |
| 02/16/2006 | US20060035836 Treatment of acute coronary syndrome with an exendin |
| 02/16/2006 | US20060035835 Novel protein, production and use thereof |
| 02/16/2006 | US20060035834 Compositions and methods for diagnosing and treating an inflammation |
| 02/16/2006 | US20060035833 Anti-angiogenic compositions and methods of use |
| 02/16/2006 | US20060035832 Anti-angiogenic compositions and methods of use |
| 02/16/2006 | US20060035831 Anti-angiogenic compositions and methods of use |
| 02/16/2006 | US20060035830 Anti-angiogenic compositions and methods of use |
| 02/16/2006 | US20060035829 Chemokine combinations to mobilize progenitor/stem cells |
| 02/16/2006 | US20060035828 administering high molecular weight ATIIIs that have been heat treated and/or associated with an oligosaccharide, particularly heparin; treating HAV, HBV, HCV, HIV and corona virus infections and diseases caused by thrombin activation |
| 02/16/2006 | US20060035827 Compositions and methods for the treatment or prevention of gallbladder disease |
| 02/16/2006 | US20060035826 Promoting growth or regeneration of neurons and treating diseases or conditions associated with loss, loss of function or dysfunction of nerve cells, in particular thalamic nerve cells, by administering polypeptide having high degree of sequence identity with native sequence Netrin G1(NGL-1) or angonist |
| 02/16/2006 | US20060035825 Alpha 5 beta 1 and its ability to regulate the cell survival pathway |
| 02/16/2006 | US20060035824 Use of acrp30 globular head to promote increases in muscle mass and muscle differentiation |
| 02/16/2006 | US20060035823 Isolated fragments of p62 nucleoporin and uses thereof |
| 02/16/2006 | US20060035822 Analogs which are topically active but systemically less active, providing therapy to subjects without the risk of systemic side effects |
| 02/16/2006 | US20060035821 Cyclosporin analogs for the treatment of immunoregulatory disorders and respiratory diseases |
| 02/16/2006 | US20060035820 Fungicides trans 1-[4-[(2-aminocyclo-hexyl)-amino]N2-[[4''(pentyloxy)[1,1':4', 1''-terphenyl]-4-yl-carbonyl]-L-ornithine]-4-[4(4-hydroxyphenyl)-L-threonine]-5-L-serine-echinocandine B trifluoroacetate; treating infections caused by Candida, Aspergillus, Cryptococcus |
| 02/16/2006 | US20060035819 Novel molecule |
| 02/16/2006 | US20060035818 Use of corticotroph-derived glycoprotein hormone to induce lipolysis |
| 02/16/2006 | US20060035817 Use of galectin-3 and galectin-7 to promote the re-epithelialization of wounds |
| 02/16/2006 | US20060035816 Providing a procoagulant membrane comprising a binding site containing phosphatidyl-L-serine; adding lactadherin to the membrane wherein the lactadherin will bind to the binding site and reduce access for interaction by a coagulation molecule |
| 02/16/2006 | US20060035814 Reagents and methods for smooth muscle therapies |
| 02/16/2006 | US20060035813 Methods and formulations comprising agonists and antagonists of nuclear hormone receptors |
| 02/16/2006 | US20060035812 Neuroprotective dietary supplement |
| 02/16/2006 | US20060035811 Methods of treating dry eye disease with lantibiotics |
| 02/16/2006 | US20060035809 Apoptosis-mimicking natural vesicles and use thereof in medical treatment |
| 02/16/2006 | US20060035374 Method and device for multiplying and differentiating cells in the presence of growth factors and of a biological matrix or of a supporting structure |
| 02/16/2006 | US20060035362 Novel human hydrolase family members and uses thereof |